Johnston P G, Lee J, Domanski M, Dressler F, Tucker E, Rothenberg M, Cunnion R E, Pizzo P A, Walsh T J
Medicine Branch, National Cancer Institute, National Institutes of Health, Bethesda 20892.
Chest. 1991 Jun;99(6):1531-3. doi: 10.1378/chest.99.6.1531.
Late recurrent Candida endocarditis (LRCE) developed on a prosthetic mitral valve 22 months after treatment for primary native mitral valve endocarditis. The LRCE was difficult to diagnose; results of two dimensional echocardiography and repeated blood cultures were negative. Only transesophageal echocardiography revealed a vegetation and only lysis centrifugation blood cultures demonstrated candidemia. Postmortem examination revealed a large Candida vegetation on the prosthetic valve and Candida in the mitral valve ring. This case and a review of the literature indicate that Candida endocarditis treated with amphotericin B and prosthetic valve replacement may recur months after treatment, and that LRCE, which is difficult to diagnose and treat, may be best prevented by lifelong antifungal suppressive therapy.